Article
ICI-induced Granulomatous Sialadenitis is Responsive to Prednisone
2026-01-26
Abstract excerpt
Immune checkpoint inhibitors (ICIs) have transformed cancer treatment but commonly cause immune-related adverse events (irAEs), whether administered as monotherapy or in combination with other oncological agents. We present the first reported case of ICI-induced granulomatous sialadenitis in a male patient in his mid-fifties with BRAF-V600E-mutated papillary thyroid carcinoma who received sequential treatment with...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1c78961b-d8ec-55d5-a60c-93628df94cfb
- DOI
- 10.64898/2026.01.21.26344113
